Nuclear medicine equipment utilize radioactive substances, which are introduced into the body either intravenously or orally in small quantities, to diagnosis and treat various diseases. These equipment create images by capturing the radiation from these radioactive medicines. This technique is used for early diagnosis of a disease, as it tracks the molecular activities within the body. In addition, it is used to examine immediate response to therapeutic interventions.
The global nuclear medicine equipment market is estimated to reach $2,647 million by 2022 from $2,012 million in 2015, growing at a CAGR of 3.9% from 2016 to 2022. Increase in prevalence of cancer, heart-related diseases, and neurological disorders has given rise to the importance of early disease diagnosis, which is expected to positively impact the market growth. The nuclear medicine equipment market is driven by the availability of high-quality equipment, rise in adoption of nuclear medicine equipment, and emergence of innovative & advanced equipment. However, high cost of these equipment and their short half-life, high hospital expense, and high cost related to diagnostic imaging services hinder the market growth.
Browse the full report @ http://www.orbisresearch.com/reports/index/nuclear-medicine-equipment-market-by-product-type-and-pet-application-and-end-user-global-opportunity-analysis-and-industry-forecast-2014-2022 .
The nuclear medicine equipment market is segmented based on product, application, end user, and geography. Based on product, the market is bifurcated into single-photon emission computed tomography (SPECT) and positron emission tomography (PET). SPECT is further segmented into standalone and hybrid SPECT, while PET into standalone and hybrid PET. By application, the market is categorized into cardiology, neurology, oncology, and others. Based on end user, it is classified into hospitals, imaging centers, and academic & research institutes. Geographically, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, and rest of Asia-Pacific), and LAMEA (Brazil, Turkey, Saudi Arabia, Republic of South Africa, Argentina, and rest of LAMEA).
The key players in the industry have adopted product launch as their key developmental strategy to expand their market foothold. For instance, in November 2016, Philips launched an advanced visual analysis and quantification platform called IntelliSpace Portal 9.0., which assists radiologists to diagnose and monitor the treatment of neurological diseases, such as multiple sclerosis and dementia.
Check the DISCOUNT on this report @ http://www.orbisresearch.com/contacts/discount/214289 .
Key market benefits: This report provides a detailed quantitative analysis of the current market trends from 2014 to 2022 to identify the prevailing opportunities.
Market estimations provided in the report are based on comprehensive analysis of the key developments in the industry.
The global market is comprehensively analyzed with respect to product type, application, end user, and geography.
In-depth analysis based on geography helps in understanding the regional market to assist in strategic business planning.
The recent developments and strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.
Purchase a copy of this report @ http://www.orbisresearch.com/contact/purchase/214289 .
For more information contact firstname.lastname@example.org
Some Points from Table of Contents:
Chapter: 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
Chapter: 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
Chapter: 3 MARKET OVERVIEW
3.1. MARKET DEFINITIONS AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. GOVERNMENT REGULATIONS
3.3.1. U.S. FDA
3.3.2. Europe CE Mark
3.3.3. Ministry of Health, Labor, and Welfare (MHLW)
3.4. REIMBURSEMENT SCENARIOS
3.5. CLINICAL TRIALS
3.6. MARKET DYNAMICS
184.108.40.206. Rise in prevalence of chronic diseases
220.127.116.11. Efficient and convenient technique
18.104.22.168. Growing awareness
22.214.171.124. Budget constraints
126.96.36.199. Lack of trained professionals
188.8.131.52. Technological advancements
184.108.40.206. Development of skilled professionals
The key players in the global nuclear medicine equipment market include:
General Electric Company
Koninklijke Philips N.V.
Mediso Medical Imaging Systems, Ltd.
Compañía Mexicana de Radiología CGR, S.A de C.V.
Request a sample of this report @ http://www.orbisresearch.com/contacts/request-sample/214289 .
For any enquires before buying, connect with us @ email@example.com
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +912064101019
Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research